MAKO Surgical Corp. Stockholders Approve Previously Announced Potential Additional Equity Funding

FORT LAUDERDALE, Fla., Jan. 27, 2009 (GLOBE NEWSWIRE) — MAKO Surgical Corp. (Nasdaq:MAKO), a medical device company focused on marketing its MAKO RIO(tm) System, a robotic arm interactive orthopedic surgical platform, and its RESTORIS(r) implants for minimally invasive orthopedic knee procedures known as MAKOplasty(r), announced today that it received necessary stockholder approval for the potential future issuance of $20 million of common stock along with related warrants to three leading healthcare investment firms as contemplated by its private placement on October 31, 2008. Of the stockholders voting at a special meeting held earlier today, approximately 99% voted to approve the potential issuance of the common stock and warrants.

Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

One Comment

  1. How much money and dilution will these people allow in this capital structure? The early employees must be looking at a lot of worthless stock. With slow sales and all the money from investors instead of buyers, I’d say this one is headed for disaster!

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button